December 15, 2009 /
MS Research Study and Reports
I first wrote a blog post of this story yesterday.
Below is another posting (even better than yesterday’s post):
Multiple Sclerosis Treatment with Adult Stem Cells
by David Prentice
December 14, 2009
The latest success story comes from Australia. Ben Leahy, 20, was in a wheelchair and experiencing vision problems when he was treated earlier in 2009. Ben is now walking after treatment with adult stem cells. The treatment involves isolating the patient’s bone marrow adult stem cells, giving the patient mild chemotherapy to destroy the rogue immune cells that are attacking the nervous system, then re-injecting the patient’s adult stem cells.
While the Australian group has not yet published their results, the technique mirrors the treatment results published in 2009 in Lancet Neurology by Dr. Richard Burt’s team at Northwestern, where they reported that they had reversed the neurological dysfunction of early-stage multiple sclerosis patients.
As Dr. Burt noted:
“This is the first time we have turned the tide on this disease.”
CLICK HERE to continue reading and to watch MS Patient videos of this treatment
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Keep up-to-date with MS related News (as seen above), when registered with us. Visit our website to register NOW. It will not take more than 30 seconds to register and once accomplished, you will then receive our weekly MS related e-Newsletter, which is currently being received in 58 countries by more than 6000 e-recipients. Click HERE to register. – Thank You
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT
Categories
Latest Blog Posts
- Ocrevus in Advanced Progressive Multiple Sclerosis (pertaining to younger and elder patients with MS)
- The Demon Within, Surviving MS – Podcast Episode 12
- Former Indiana QB Fernando Mendoza donates $500K to University of Miami MS research initiative
- Major Breakthrough: FDA APPROVES OCREVUS FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS IN PEDIATRIC PATIENTS 10 YEARS OF AGE AND OLDER
- Having 2nd autoimmune disease does not speed up MS progression: Study
- MS, Motherhood, and Mental Health
- Multiple Sclerosis in Children
- Men’s online MS Group asking other Men with MS to Join the Conversation
- Enough on estrogen. Let’s Learn more of Low T, and the Facts for the Men
- Brain sugar levels act as signal for myelin growth, study finds
- MS and sleep: Tips for getting better rest
- What People SHOULD Say to Someone Living with Multiple Sclerosis
- New walking station brings gait therapy right into MS patients’ homes
- Brain inflammation may help repair myelin, animal study shows
- People Wait an Average of 50 Days to See a Neurologist, and People with MS Wait Even Longer: What Can We Do to Improve Access to MS Care?
- Key Findings on GLP-1 Use in MS
- Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS
- Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses
- This Blood Test Tracks MS Activity? (Octave Explained)
- Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS
